Proteome Sciences plc
PMSNF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $5 | $5 | $23,736 | $22,593 |
| % Growth | -2.8% | -100% | 5.1% | – |
| Cost of Goods Sold | $4 | $3 | $3 | $2 |
| Gross Profit | $1 | $2 | $5 | $3 |
| % Margin | 13.7% | 32.8% | 0% | 0% |
| R&D Expenses | $1 | $1 | $0 | $0 |
| G&A Expenses | $3 | $3 | $3 | $2 |
| SG&A Expenses | $3 | $3 | $3 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1 | -$1 | $0 | -$0 |
| Operating Expenses | $3 | $3 | $3 | $3 |
| Operating Income | -$2 | -$2 | $2 | $0 |
| % Margin | -48.1% | -32.2% | 0% | 0% |
| Other Income/Exp. Net | -$1 | -$1 | -$0 | -$0 |
| Pre-Tax Income | -$3 | -$2 | $1 | $0 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | -$3 | -$2 | $1 | $0 |
| % Margin | -69.7% | -48.6% | 0% | 0% |
| EPS | -0.012 | -0.008 | 0.005 | 0 |
| % Growth | -38.6% | -284.4% | 2,150% | – |
| EPS Diluted | -0.012 | -0.008 | 0.004 | 0 |
| Weighted Avg Shares Out | 295 | 294 | 308 | 362 |
| Weighted Avg Shares Out Dil | 295 | 295 | 309 | 302 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $0 | $0 |
| Depreciation & Amortization | $1 | $0 | $0 | $0 |
| EBITDA | -$2 | -$1 | $2 | $1 |
| % Margin | -31% | -22.6% | 0% | 0% |